Trial Profile
Evaluation of Brain Activation in Complete Responders and Partial Responders Following Acute Administration of Treximet (Sumatriptan and Naproxen).
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 24 Jul 2023
Price :
$35
*
At a glance
- Drugs Naproxen sodium/sumatriptan (Primary)
- Indications Migraine
- Focus Therapeutic Use
- Acronyms TREX
- 01 Oct 2012 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 07 May 2010 New trial record